Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)

Clinical trial NCT02826252 · COMPLETED

Trial details

NCT number: NCT02826252
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Hypertension, Pulmonary

Start date: 2016-09-15
Primary completion: 2016-11-15
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.